<?xml version="1.0" encoding="UTF-8"?>
<results title="drug">
 <result pre="recovery but with insignificant clinical benefits and the antimalarial drug," exact="hydroxychloroquine" post="has been red flagged by USFDA for use as"/>
 <result pre="Remdesivir, a nucleotide analogue inhibitor of RdRp and antimalarial drug" exact="chloroquine" post="effectively inhibited the SARS-CoV-2 infection inÂ vitro (M. Wang"/>
 <result pre="vitro (M. Wang etÂ al., 2020). Hydroxychloroquine, an analogue of" exact="chloroquine" post="is also a drug candidate after inÂ vitro (Yao"/>
 <result pre="pose and binding interactions of N3 (i), GS-441524 (ii) and" exact="Hydroxychloroquine" post="(iii) with SARS-Cov-2 Mpro. Figure 2. Docked pose and"/>
 <result pre="pose and binding interactions of MLN-4765 (i), GS-441524 (ii) and" exact="Hydroxychloroquine" post="(iii) with ACE2. Table 1. Docking scores of N3/MLN-4760"/>
 <result pre="SARS-CoV-2 infected patients (Rhoades, 2020). Remdesivir is a prodrug of" exact="adenosine" post="triphosphate (ATP) analog, GS-441524 that interferes with the action"/>
 <result pre="The 2D and 3D docking pose of both remdesivir and" exact="hydroxychloroquine" post="in SARS-CoV-2 Mpro and ACE2 is presented in Figure"/>
 <result pre="- PubMed - NCBI, n.d.). Avicularin elevated the sensitivity of" exact="cisplatin" post="in drug resistant gastric cancer cells in inÂ vitro"/>
 <result pre="crude extract have less bioavailability as compared to encapsulated spray" exact="dried" post="formulations. Like delphinidin 3,5-diglucoside the next two leads (Scutellarein"/>
 <result pre="Triglycosides from Buddleja Madagascariensis.Phytochemistry, 48(4), 739â€&quot;42. 10.1016/S0031-9422(97)01043-1. collab: FDA (2020)." exact="Hydroxychloroquine" post="fact sheet for health care providers, 1â€&quot;7. FilipiakK., HidalgoM.,"/>
 <result pre="HonorÃ©S., ColsonP., ChabriÃ¨reE., La ScolaB., RolainJ.-M., BrouquiP., &amp;amp; RaoultD. (2020)." exact="Hydroxychloroquine" post="and azithromycin as a treatment of COVID-19: Results of"/>
 <result pre="ChabriÃ¨reE., La ScolaB., RolainJ.-M., BrouquiP., &amp;amp; RaoultD. (2020). Hydroxychloroquine and" exact="azithromycin" post="as a treatment of COVID-19: Results of an open-label"/>
 <result pre="LiuJ., XuM., ShiZ., HuZ., ZhongW., &amp;amp; XiaoG. (2020). Remdesivir and" exact="chloroquine" post="effectively inhibit the recently emerged novel coronavirus (2019-NCoV) inÂ"/>
 <result pre="vitro antiviral activity and projection of optimized dosing design of" exact="hydroxychloroquine" post="for the treatment of severe acute respiratory syndrome coronavirus"/>
</results>
